WO2009044899A1 - 細胞の増殖を制御する核酸 - Google Patents
細胞の増殖を制御する核酸 Download PDFInfo
- Publication number
- WO2009044899A1 WO2009044899A1 PCT/JP2008/068109 JP2008068109W WO2009044899A1 WO 2009044899 A1 WO2009044899 A1 WO 2009044899A1 JP 2008068109 W JP2008068109 W JP 2008068109W WO 2009044899 A1 WO2009044899 A1 WO 2009044899A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cell
- proliferation
- nucleic acid
- regulating
- acid capable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
- C12N2310/141—MicroRNAs, miRNAs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2330/00—Production
- C12N2330/10—Production naturally occurring
Abstract
細胞の増殖抑制剤または増殖促進剤、細胞の増殖異常に起因する疾患の診断薬または治療薬、アポトーシス誘導剤、マイクロRNAなどの核酸の標的遺伝子の発現抑制剤または発現促進剤、細胞の増殖抑制方法または増殖促進方法に関する。
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08835543A EP2208499A4 (en) | 2007-10-03 | 2008-10-03 | NUCLEIC ACID FOR REGULATING CELL PROLIFERATION |
US12/681,417 US20100305188A1 (en) | 2007-10-03 | 2008-10-03 | Nucleic acid capable of regulating the proliferation of cell |
JP2009536125A JPWO2009044899A1 (ja) | 2007-10-03 | 2008-10-03 | 細胞の増殖を制御する核酸 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007260393 | 2007-10-03 | ||
JP2007-260393 | 2007-10-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009044899A1 true WO2009044899A1 (ja) | 2009-04-09 |
Family
ID=40526314
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/068109 WO2009044899A1 (ja) | 2007-10-03 | 2008-10-03 | 細胞の増殖を制御する核酸 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20100305188A1 (ja) |
EP (1) | EP2208499A4 (ja) |
JP (1) | JPWO2009044899A1 (ja) |
WO (1) | WO2009044899A1 (ja) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011108930A1 (en) * | 2010-03-04 | 2011-09-09 | Interna Technologies Bv | A MiRNA MOLECULE DEFINED BY ITS SOURCE AND ITS DIAGNOSTIC AND THERAPEUTIC USES IN DISEASES OR CONDITIONS ASSOCIATED WITH EMT |
WO2011111715A1 (ja) * | 2010-03-09 | 2011-09-15 | 協和発酵キリン株式会社 | 細胞周期を制御する核酸 |
WO2012161124A1 (ja) * | 2011-05-20 | 2012-11-29 | 国立大学法人愛媛大学 | マイクロrna又はその発現系を含む組成物 |
JP2013091611A (ja) * | 2011-10-25 | 2013-05-16 | Gifu Univ | 間葉系細胞の分化調節剤およびこれを用いた医薬、並びに間葉系細胞への分化調節作用を有する物質のスクリーニング方法 |
WO2014126233A1 (ja) * | 2013-02-15 | 2014-08-21 | 国立大学法人東京医科歯科大学 | マイクロrnaの測定方法、並びに、がん治療剤及びこれを含有するがん治療のための医薬組成物 |
US9441222B2 (en) | 2011-01-11 | 2016-09-13 | Interna Technologies B.V. | MiRNA for treating diseases and conditions associated with neo-angiogenesis |
US9682095B2 (en) | 2010-07-06 | 2017-06-20 | Interna Technologies B.V. | MiRNA and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated BRAF pathway |
US20170211074A1 (en) * | 2016-01-21 | 2017-07-27 | University Of South Carolina | miRNA-489 IN TREATMENT OF BREAST CANCER |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE46843E1 (en) | 2005-03-14 | 2018-05-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for evaluating graft survival in a solid organ transplant recipient |
US7741038B2 (en) | 2005-03-14 | 2010-06-22 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for evaluating graft survival in a solid organ transplant recipient |
US9957569B2 (en) * | 2005-09-12 | 2018-05-01 | The Regents Of The University Of Michigan | Recurrent gene fusions in prostate cancer |
CA2814598A1 (en) | 2005-09-12 | 2007-03-22 | The Regents Of The University Of Michigan | Recurrent gene fusions in prostate cancer |
EP2487257B1 (en) | 2006-01-05 | 2015-07-01 | The Ohio State University Research Foundation | MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers |
ES2446362T3 (es) | 2006-03-20 | 2014-03-07 | The Ohio State University Research Foundation | Huellas de microARN durante megacariocipoyesis humana |
CA2668961A1 (en) * | 2006-11-08 | 2008-05-15 | The Regents Of The University Of Michigan | Spink1 as a prostate cancer marker and uses thereof |
AU2008275303B2 (en) | 2007-07-06 | 2012-05-03 | The Regents Of The University Of Michigan | MIPOL1-ETV1 gene rearrangements |
CN101835902B (zh) | 2007-08-03 | 2014-03-26 | 俄亥俄州立大学研究基金会 | 编码ncrna的超保守区域 |
CN101424640B (zh) * | 2007-11-02 | 2012-07-25 | 江苏命码生物科技有限公司 | 血清中微小核糖核酸的检测方法和用于检测的试剂盒、生物芯片及其制作和应用方法 |
EP2257647B1 (en) * | 2008-02-28 | 2016-09-14 | The Ohio State University Research Foundation | Micro rna-based methods and compositions for the diagnosis of gastric cancer |
EP2387618B1 (en) * | 2009-01-15 | 2014-05-21 | The Board of Trustees of The Leland Stanford Junior University | Biomarker panel for diagnosis and prediction of graft rejection |
EP2228444A1 (en) * | 2009-03-09 | 2010-09-15 | Julius-Maximilians-Universität Würzburg | microRNA for diagnostic and therapeutic purposes in cardiovascular diseases |
WO2011034906A2 (en) | 2009-09-17 | 2011-03-24 | The Regents Of The University Of Michigan | Recurrent gene fusions in prostate cancer |
AU2010321555B2 (en) | 2009-11-23 | 2015-10-15 | The Ohio State University | Materials and methods useful for affecting tumor cell growth, migration and invasion |
WO2011068829A1 (en) | 2009-12-02 | 2011-06-09 | The Board Of Trustees Of The Leland Stanford Junior University | Biomarkers for determining an allograft tolerant phenotype |
US9535075B2 (en) | 2010-03-25 | 2017-01-03 | The Board Of Trustees Of The Leland Stanford Junior University | Protein and gene biomarkers for rejection of organ transplants |
RU2585491C2 (ru) | 2010-06-04 | 2016-05-27 | Борд Оф Риджентс, Зе Юниверсити Оф Техас Систем | Регуляция метаболизма с помощью mir-378 |
CA2816603A1 (en) | 2010-11-12 | 2012-05-18 | The Ohio State University Research Foundation | Materials and methods related to microrna-21, mismatch repair, and colorectal cancer |
AU2011329066B2 (en) | 2010-11-15 | 2017-03-09 | The Ohio State University Research Foundation | Controlled release mucoadhesive systems |
KR101852440B1 (ko) | 2010-11-19 | 2018-04-27 | (주)아모레퍼시픽 | 듀옥스 2 miRNA를 포함하는 피부 세포 분화 조절용 조성물 |
US8945556B2 (en) | 2010-11-19 | 2015-02-03 | The Regents Of The University Of Michigan | RAF gene fusions |
US9233121B2 (en) | 2011-03-11 | 2016-01-12 | Board Of Regents Of The University Of Nebraska | Compositions and methods for the treatment of cancer |
WO2012167145A2 (en) * | 2011-06-01 | 2012-12-06 | University Of Southern California | Genome-scale analysis of aberrant dna methylation in colorectal cancer |
WO2012177639A2 (en) * | 2011-06-22 | 2012-12-27 | Alnylam Pharmaceuticals, Inc. | Bioprocessing and bioproduction using avian cell lines |
EP2766500A4 (en) | 2011-10-14 | 2015-10-14 | Univ Ohio State | METHODS AND MATERIALS RELATED TO OVARIAN CANCER |
WO2013057567A1 (en) * | 2011-10-19 | 2013-04-25 | Council Of Scientific And Industrial Research (C.S.I.R.) | Biomarkers useful for detection of types, grades and stages of human breast cancer |
EP2785839A2 (en) * | 2011-11-30 | 2014-10-08 | University of Bremen | Expression of mirnas in placental tissue |
US9481885B2 (en) | 2011-12-13 | 2016-11-01 | Ohio State Innovation Foundation | Methods and compositions related to miR-21 and miR-29a, exosome inhibition, and cancer metastasis |
CA2866052A1 (en) * | 2012-01-20 | 2013-07-25 | The Ohio State University | Breast cancer biomarker signatures for invasiveness and prognosis |
US9334498B2 (en) | 2012-05-10 | 2016-05-10 | Uab Research Foundation | Methods and compositions for modulating MIR-204 activity |
EP2859103B1 (en) * | 2012-06-06 | 2019-04-17 | Boehringer Ingelheim International GmbH | CELL ENGINEERING USING RNAs |
EP3556215A1 (en) * | 2012-12-14 | 2019-10-23 | Celularity, Inc. | Anoikis resistant placental stem cells and uses thereof |
JP2018523823A (ja) * | 2015-08-04 | 2018-08-23 | セルジーン コーポレイション | 慢性リンパ球性白血病の治療方法及び免疫調節療法に対する臨床的感度の予測因子としてのバイオマーカーの利用 |
SE540173C2 (en) * | 2016-04-20 | 2018-04-24 | Hiloprobe Ab | Marker genes for colorectal cancer classification, method for judging lymph node metastasis for prognosis of colorectal cancer and kit therefor |
CN108531615B (zh) * | 2018-04-24 | 2021-11-12 | 河南农业大学 | 一种鸡HS6ST3基因43bp indel多态性标记及其应用、检测引物、试剂盒 |
CN108721319B (zh) * | 2018-05-28 | 2020-04-28 | 中南大学 | 抑制circ_CLASP2的试剂在制备鼻咽癌治疗制剂中的应用及制剂 |
WO2020041308A1 (en) * | 2018-08-20 | 2020-02-27 | University Of Georgia Research Foundation, Inc. | Compositions and methods for increasing beiging of white adipose tissue |
CA3172754A1 (en) * | 2020-02-24 | 2021-09-02 | The Trustees Of Indiana University | Therapeutic delivery of locked nucleic acid conjugated antisense mir-1 |
CN115572764A (zh) * | 2022-03-30 | 2023-01-06 | 江苏鹍远生物技术有限公司 | 一组肿瘤检测标志物及其用途 |
CN115920053A (zh) * | 2022-12-23 | 2023-04-07 | 河北医科大学第四医院 | Crx在肺癌诊断、治疗中的应用 |
CN116516016A (zh) * | 2023-04-11 | 2023-08-01 | 西北农林科技大学 | 一种与绵羊尾长相关的单核苷酸多态性标记及其应用 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997016538A1 (fr) | 1995-10-31 | 1997-05-09 | Dnavec Research Inc. | Vecteur de virus d'arn a brin negatif possedant une activite de replication autonome |
WO1997016539A1 (fr) | 1995-11-01 | 1997-05-09 | Dnavec Research Inc. | Virus sendai recombinant |
US20070065844A1 (en) * | 2005-06-08 | 2007-03-22 | Massachusetts Institute Of Technology | Solution-based methods for RNA expression profiling |
US20070142313A1 (en) * | 2005-12-15 | 2007-06-21 | Board Of Regents, The University Of Texas System | MicroRNA1 therapies |
WO2007081720A2 (en) * | 2006-01-05 | 2007-07-19 | The Ohio State University Research Foundation | Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer |
WO2007081680A2 (en) * | 2006-01-05 | 2007-07-19 | The Ohio State University Research Foundation | Microrna expression abnormalities in pancreatic endocrine and acinar tumors |
WO2007147409A2 (en) * | 2006-06-19 | 2007-12-27 | Københavns Universitet | Ribozyme mediated stabilization of polynucleotides |
WO2008103755A1 (en) * | 2007-02-20 | 2008-08-28 | Mayo Foundation For Medical Education And Research | Treating cancer with viral nucleic acid |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1713938A2 (en) * | 2004-02-09 | 2006-10-25 | Thomas Jefferson University | DIAGNOSIS AND TREATMENT OF CANCERS WITH MicroRNA LOCATED IN OR NEAR CANCER-ASSOCIATED CHROMOSOMAL FEATURES |
EP2471924A1 (en) * | 2004-05-28 | 2012-07-04 | Asuragen, INC. | Methods and compositions involving microRNA |
EP2302055B1 (en) * | 2004-11-12 | 2014-08-27 | Asuragen, Inc. | Methods and compositions involving miRNA and miRNA inhibitor molecules |
EP2487257B1 (en) * | 2006-01-05 | 2015-07-01 | The Ohio State University Research Foundation | MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers |
JP2011505143A (ja) * | 2007-11-30 | 2011-02-24 | ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション | マイクロrna発現プロファイリング及び肺癌における末梢血ターゲティング |
WO2009100161A2 (en) * | 2008-02-04 | 2009-08-13 | Fred Hutchinson Cancer Research Center | Epigenetic silencing of mir-342 in colorectal cancer |
-
2008
- 2008-10-03 JP JP2009536125A patent/JPWO2009044899A1/ja not_active Abandoned
- 2008-10-03 US US12/681,417 patent/US20100305188A1/en not_active Abandoned
- 2008-10-03 WO PCT/JP2008/068109 patent/WO2009044899A1/ja active Application Filing
- 2008-10-03 EP EP08835543A patent/EP2208499A4/en not_active Withdrawn
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997016538A1 (fr) | 1995-10-31 | 1997-05-09 | Dnavec Research Inc. | Vecteur de virus d'arn a brin negatif possedant une activite de replication autonome |
WO1997016539A1 (fr) | 1995-11-01 | 1997-05-09 | Dnavec Research Inc. | Virus sendai recombinant |
US20070065844A1 (en) * | 2005-06-08 | 2007-03-22 | Massachusetts Institute Of Technology | Solution-based methods for RNA expression profiling |
US20070142313A1 (en) * | 2005-12-15 | 2007-06-21 | Board Of Regents, The University Of Texas System | MicroRNA1 therapies |
WO2007081720A2 (en) * | 2006-01-05 | 2007-07-19 | The Ohio State University Research Foundation | Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer |
WO2007081680A2 (en) * | 2006-01-05 | 2007-07-19 | The Ohio State University Research Foundation | Microrna expression abnormalities in pancreatic endocrine and acinar tumors |
WO2007147409A2 (en) * | 2006-06-19 | 2007-12-27 | Københavns Universitet | Ribozyme mediated stabilization of polynucleotides |
WO2008103755A1 (en) * | 2007-02-20 | 2008-08-28 | Mayo Foundation For Medical Education And Research | Treating cancer with viral nucleic acid |
Non-Patent Citations (104)
Title |
---|
"Molecular Cloning,3rd edition", 2001, COLD SPRING HARBOR PRESS, COLD SPRING HARBOR, NY |
ACC. CHEM. RES., vol. 32, 1999, pages 624 |
ADAMS B.D. ET AL.: "The Micro-Ribonucleic Acid (miRNA) miR-206 Targets the Human Estrogen Receptor- (ER) and Represses ER Messenger RNA and Protein Expression in Breast Cancer Cell Lines", MOL. ENDOCRINOL., vol. 5, 21 May 2007 (2007-05-21), pages 1132 - 1147, XP008133173 * |
BIOCHEMISTRY, vol. 28, 1989, pages 9508 - 9514 |
BIOSCIENCE AND INDUSTRY, vol. 50, 1992, pages 322 |
BIOTECHNIQUES, vol. 11, 1991, pages 474 - 485 |
BIOTECHNOLOGY, vol. 9, 1992, pages 358 |
CANCER CELL, vol. 9, 2006, pages 435 - 443 |
CANCER RESEARCH, vol. 64, 2004, pages 3753 - 3756 |
CANCER RESEARCH, vol. 66, 2006, pages 11590 - 11593 |
CANCER RESEARCH, vol. 67, 2007, pages 1424 - 1429 |
CANCER RESEARCH, vol. 67, 2007, pages 7713 - 7722 |
CELL TECHNOLOGY, vol. 16, 1997, pages 1463 |
CELL, vol. 113, 2003, pages 673 - 676 |
CELL, vol. 120, 2005, pages 635 - 647 |
CELL, vol. 124, 2006, pages 1169 - 1181 |
CELL, vol. 27, 1981, pages 223 - 231 |
CHEMISTRY & BIOLOGY, vol. 6, 1999, pages R33 |
CIRCULATION RESEARCH, vol. 82, 1998, pages 1023 |
CIRCULATION, vol. 83, 1992, pages 2007 - 2011 |
CURRENT BIOLOGY, vol. 15, 2005, pages R458 - R460 |
CURRENT OPINION IN CHEMICAL BIOLOGY, vol. 3, 1999, pages 274 |
EXPERIMENTAL NEPHROLOGY, vol. 5, 1997, pages 429 |
FEMS MICROBIOLOGY REVIEWS, vol. 23, 1999, pages 257 |
FRONTIERS IN BIOSCIENCE, vol. 4, 1999, pages D497 |
GENES & DEVELOPMENT, vol. 15, 2000, pages 188 - 200 |
GENES DEV., vol. 13, 1999, pages 3191 |
GENOME RES., vol. 6, 1996, pages 639 |
GENOMICS, vol. 16, 1993, pages 325 - 332 |
HUM. GENE THER., vol. 3, 1991, pages 147 - 154 |
HUM. GENE THER., vol. 3, 1992, pages 267 - 275 |
HUM. GENE THER., vol. 3, 1992, pages 399 |
J. AM. CHEM. SOC., vol. 122, 2000, pages 6900 |
J. AM. CHEM. SOC., vol. 123, 2001, pages 4653 |
J. BIOL. CHEM., vol. 264, 1989, pages 12126 - 12129 |
J. BIOL. CHEM., vol. 264, 1989, pages 16985 - 16987 |
J. BIOL. CHEM., vol. 266, 1991, pages 14338 - 14342 |
J. IMMUNOL. METH., vol. 160, 1993, pages 81 - 88 |
J. IMMUNOL. METH., vol. 65, 1983, pages 55 - 63 |
J. MOL. BIOL., vol. 215, 1990, pages 403 |
KAGAKU, vol. 46, 1991, pages 681 |
METHODS IN ENZYMOLOGY, vol. 183, 1990, pages 63 |
METHODS IN ENZYMOLOGY, vol. 254, 1995, pages 419 |
MOLECULAR AND CELLULAR BIOLOGY, vol. 27, 2007, pages 2240 - 2252 |
MUTAT. RES., vol. 288, 1993, pages 103 - 112 |
NATURE GENET., vol. 8, 1994, pages 42 |
NATURE GENETICS, vol. 9, 1996, pages 103 - 104 |
NATURE METHOD, vol. 3, 2006, pages 27 |
NATURE REVIEWS CANCER, vol. 6, 2006, pages 259 - 269 |
NATURE REVIEWS GENETICS, vol. 5, 2004, pages 522 - 531 |
NATURE, vol. 294, 1981, pages 92 - 94 |
NATURE, vol. 295, 1982, pages 116 - 119 |
NATURE, vol. 432, 2004, pages 226 |
NATURE, vol. 432, 2004, pages 226 - 230 |
NATURE, vol. 435, 2005, pages 823 - 833 |
NATURE, vol. 435, 2005, pages 839 - 843 |
NATURE, vol. 447, 2007, pages 1130 - 1134 |
NIPPON RINSHO - JAPANESE JOURNAL OF CLINICAL MEDICINE, vol. 54, 1996, pages 2583 |
NIPPON RINSHO - JAPANESE JOURNAL OF CLINICAL MEDICINE, vol. 56, 1998, pages 563 |
NUCLEIC ACID RESEARCH, vol. 32, 2004, pages E188 |
NUCLEIC ACID RESEARCH, vol. 32, 2004, pages EL75 |
NUCLEIC ACID RESEARCH, vol. 33, 2005, pages E179 |
NUCLEIC ACIDS RESEARCH, vol. 26, 1998, pages 5237 |
NUCLEIC ACIDS RESEARCH, vol. 31, 2003, pages 3406 - 3415 |
NUCLEIC ACIDS RESEARCH, vol. 31, 2003, pages 3429 - 3431 |
NUCLEIC ACIDS RESEARCH, vol. 32, 2004, pages E43 |
NUCLEIC ACIDS RESEARCH, vol. 34, 2006, pages 1765 - 1771 |
ONCOGENES, vol. 26, 2007, pages 2799 - 2803 |
ONCOLOGY REPORTS, vol. 16, 2006, pages 845 - 850 |
PROC. NATL. ACAD. SCI. USA, vol. 101, 2004, pages 2999 - 3004 |
PROC. NATL. ACAD. SCI. USA, vol. 101, 2004, pages 9740 - 9744 |
PROC. NATL. ACAD. SCI. USA, vol. 102, 2005, pages 3627 - 3632 |
PROC. NATL. ACAD. SCI. USA, vol. 104, 2007, pages 15472 - 15477 |
PROC. NATL. ACAD. SCI. USA, vol. 77, 1980, pages 5399 - 5403 |
PROC. NATL. ACAD. SCI. USA, vol. 77, 1980, pages 7380 - 7384 |
PROC. NATL. ACAD. SCI. USA, vol. 84, 1987, pages 7413 - 7417 |
PROC. NATL. ACAD. SCI. USA, vol. 87, 1990, pages 3410 - 3414 |
PROC. NATL. ACAD. SCI. USA, vol. 87, 1990, pages 4033 - 4037 |
PROC. NATL. ACAD. SCI. USA, vol. 87, 1991, pages 3655 - 3659 |
PROC. NATL. ACAD. SCI. USA, vol. 88, 1991, pages 4255 - 4259 |
PROC. NATL. ACAD. SCI. USA, vol. 88, 1991, pages 8850 - 8854 |
PROC. NATL. ACAD. SCI. USA, vol. 99, 2002, pages 15524 - 15529 |
RNA, vol. 13, 2007, pages 151 - 159 |
RNA, vol. 9, 2003, pages 277 - 279 |
RNAI METHOD AND ANTISENSE METHOD, KODANSHA, 2005 |
SAIBO KOGAKU, vol. 16, 1997, pages 1463 - 1473 |
SCIENCE, vol. 209, 1980, pages 1414 - 1422 |
SCIENCE, vol. 224, 1984, pages 994 - 996 |
SCIENCE, vol. 247, 1990, pages 1465 - 1468 |
SCIENCE, vol. 249, 1990, pages 1285 - 1288 |
SCIENCE, vol. 294, 2001, pages 853 - 858 |
SCIENCE, vol. 294, 2001, pages 858 - 862 |
SCIENCE, vol. 303, 2004, pages 83 - 86 |
See also references of EP2208499A4 * |
SEMIN. ONCOL., vol. 11, 1984, pages 285 - 298 |
SHARMISTHA PAL ET AL.: "Low levels of miR-92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma", EMBO J., vol. 26, no. 15, 8 August 2007 (2007-08-08), pages 3558 - 3569, XP008133172 * |
TOM STRACHAN AND ANDREW P. READ: "Human Genetics", 1996, BIOS SCIENTIFIC PUBLISHERS LIMITED |
TRENDS GENET., vol. 7, 1991, pages 314 |
TRENDS GENET., vol. 7, 1991, pages 5 |
TRENDS IN BIOTECHNOLOGY, vol. 10, 1992, pages 132 |
TRENDS IN BIOTECHNOLOGY, vol. 10, 1992, pages 152 |
TRENDS IN BIOTECHNOLOGY, vol. 10, 1992, pages 87 |
TRENDS IN BIOTECHNOLOGY, vol. 16, 1998, pages 438 |
VIROLOGY, vol. 52, 1973, pages 456 - 467 |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3214174A1 (en) * | 2010-03-04 | 2017-09-06 | InteRNA Technologies B.V. | A mirna molecule defined by its source and its diagnostic and therapeutic uses in diseases or conditions associated with emt |
US9161947B2 (en) | 2010-03-04 | 2015-10-20 | Interna Technologies B.V. | MiRNA molecule defined by its source and its diagnostic and therapeutic uses in diseases or conditions associated with EMT |
WO2011108930A1 (en) * | 2010-03-04 | 2011-09-09 | Interna Technologies Bv | A MiRNA MOLECULE DEFINED BY ITS SOURCE AND ITS DIAGNOSTIC AND THERAPEUTIC USES IN DISEASES OR CONDITIONS ASSOCIATED WITH EMT |
WO2011111715A1 (ja) * | 2010-03-09 | 2011-09-15 | 協和発酵キリン株式会社 | 細胞周期を制御する核酸 |
US9682095B2 (en) | 2010-07-06 | 2017-06-20 | Interna Technologies B.V. | MiRNA and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated BRAF pathway |
US9441222B2 (en) | 2011-01-11 | 2016-09-13 | Interna Technologies B.V. | MiRNA for treating diseases and conditions associated with neo-angiogenesis |
WO2012161124A1 (ja) * | 2011-05-20 | 2012-11-29 | 国立大学法人愛媛大学 | マイクロrna又はその発現系を含む組成物 |
JP6011945B2 (ja) * | 2011-05-20 | 2016-10-25 | 公一 中城 | マイクロrna又はその発現系を含む組成物 |
JP2013091611A (ja) * | 2011-10-25 | 2013-05-16 | Gifu Univ | 間葉系細胞の分化調節剤およびこれを用いた医薬、並びに間葉系細胞への分化調節作用を有する物質のスクリーニング方法 |
JPWO2014126233A1 (ja) * | 2013-02-15 | 2017-02-02 | 国立大学法人 東京医科歯科大学 | マイクロrnaの測定方法、並びに、がん治療剤及びこれを含有するがん治療のための医薬組成物 |
WO2014126233A1 (ja) * | 2013-02-15 | 2014-08-21 | 国立大学法人東京医科歯科大学 | マイクロrnaの測定方法、並びに、がん治療剤及びこれを含有するがん治療のための医薬組成物 |
US9994843B2 (en) | 2013-02-15 | 2018-06-12 | National University Corporation Tokyo Medical And Dental University | Method for assaying microRNA, cancer therapeutic agent, and medicinal composition containing same for cancer therapy |
JP2018143248A (ja) * | 2013-02-15 | 2018-09-20 | 国立大学法人 東京医科歯科大学 | マイクロrnaの測定方法、並びに、がん治療剤及びこれを含有するがん治療のための医薬組成物 |
US10876115B2 (en) | 2013-02-15 | 2020-12-29 | National University Corporation Tokyo Medical And Dental University | Method for assaying MicroRNA, cancer therapeutic agent, and medical composition containing same for cancer therapy |
US20170211074A1 (en) * | 2016-01-21 | 2017-07-27 | University Of South Carolina | miRNA-489 IN TREATMENT OF BREAST CANCER |
US10053696B2 (en) * | 2016-01-21 | 2018-08-21 | University Of South Carolina | MiRNA-489 in treatment of breast cancer |
Also Published As
Publication number | Publication date |
---|---|
EP2208499A1 (en) | 2010-07-21 |
JPWO2009044899A1 (ja) | 2011-02-17 |
US20100305188A1 (en) | 2010-12-02 |
EP2208499A4 (en) | 2011-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009044899A1 (ja) | 細胞の増殖を制御する核酸 | |
WO2008073919A3 (en) | Mir-20 regulated genes and pathways as targets for therapeutic intervention | |
WO2008154333A3 (en) | Mir-34 regulated genes and pathways as targets for therapeutic intervention | |
WO2009070805A3 (en) | Mir-124 regulated genes and pathways as targets for therapeutic intervention | |
WO2009086156A3 (en) | Mir-10 regulated genes and pathways as targets for therapeutic intervention | |
WO2008073920A3 (en) | Mir-21 regulated genes and pathways as targets for therapeutic intervention | |
WO2008036741A3 (en) | Mir-200 regulated genes and pathways as targets for therapeutic intervention | |
WO2011133871A3 (en) | 5'-end derivatives | |
WO2011005860A3 (en) | 5' phosphate mimics | |
WO2009108856A3 (en) | Microrna signatures associated with human chronic lymphocytic leukemia (ccl) and uses thereof | |
WO2008085797A8 (en) | miR-16 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION | |
WO2011123621A3 (en) | 2' and 5' modified monomers and oligonucleotides | |
WO2010018563A3 (en) | Compositions and methods for the prognosis of lymphoma | |
WO2008073922A3 (en) | Functions and targets of let-7 micro rnas | |
WO2009108866A3 (en) | Microrna signatures associated with cytogenetics and prognosis in acute myeloid leukemia (aml) and uses thereof | |
WO2009121152A8 (en) | Gene signatures | |
WO2008082730A3 (en) | Biomarkers of target modulation, efficacy, diagnosis and/or prognosis for raf inhibitors | |
WO2009111643A3 (en) | Microrna markers for recurrence of colorectal cancer | |
WO2011082310A3 (en) | Methods and compositions for targeted polynucleotide modification | |
WO2008073921A3 (en) | Mir-126 regulated genes and pathways as targets for therapeutic intervention | |
WO2009154835A3 (en) | Compositions and methods related to mir-16 and therapy of prostate cancer | |
WO2008036776A3 (en) | Mir-15, mir-26, mir -31,mir -145, mir-147, mir-188, mir-215, mir-216 mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention | |
WO2009014650A3 (en) | Recombinant vibrio cholerae exotoxins | |
EP2374884A3 (en) | Human miRNAs isolated from mesenchymal stem cells | |
WO2011043809A9 (en) | Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08835543 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009536125 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008835543 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12681417 Country of ref document: US |